These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38143738)

  • 21. [Subacute cutaneous lupus erythematosus and cancer: two cases and literature review].
    Gantzer A; Regnier S; Cosnes A; Ortonne N; Wolkenstein P; Bagot M; Duong TA
    Ann Dermatol Venereol; 2011 May; 138(5):409-17. PubMed ID: 21570567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rowell's Syndrome Triggered by Omeprazole.
    Pozharashka J; Dourmishev L; Balabanova M; Vassileva S; Miteva L
    Acta Dermatovenerol Croat; 2019 Jun; 27(2):124-126. PubMed ID: 31351509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cemiplimab in advanced cutaneous squamous cell carcinoma.
    Naik PP
    Dermatol Ther; 2021 Nov; 34(6):e15184. PubMed ID: 34716727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo subacute cutaneous lupus erythematosus-like eruptions in the setting of programmed death-1 or programmed death ligand-1 inhibitor therapy: clinicopathological correlation.
    Bui AN; Hirner J; Singer SB; Eberly-Puleo A; Larocca C; Lian CG; LeBoeuf NR
    Clin Exp Dermatol; 2021 Mar; 46(2):328-337. PubMed ID: 32939795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic lupus erythematosus: clinical expression and anti-Ro/SS--a response in patients with and without lesions of subacute cutaneous lupus erythematosus.
    López-Longo FJ; Monteagudo I; González CM; Grau R; Carreño L
    Lupus; 1997; 6(1):32-9. PubMed ID: 9116716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cemiplimab in cutaneous squamous cell carcinomas (SCC): an overview and a clinical case.
    Ghidini A; Santangelo D; Vaccaro G; Chillura M; Petrelli F
    Oral Oncol; 2022 May; 128():105847. PubMed ID: 35367788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Widespread subacute cutaneous lupus erythematosus in a patient receiving checkpoint inhibitor immunotherapy with ipilimumab and nivolumab.
    Kosche C; Owen JL; Choi JN
    Dermatol Online J; 2019 Oct; 25(10):. PubMed ID: 31735010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart.
    Marzano AV; Lazzari R; Polloni I; Crosti C; Fabbri P; Cugno M
    Br J Dermatol; 2011 Aug; 165(2):335-41. PubMed ID: 21564069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Paraneoplastic subacute cutaneous lupus erythematosus].
    Rezazadegan R; Koushk-Jalali B; Kuntz T; Oellig F; Tigges C; Kreuter A
    Z Rheumatol; 2021 Mar; 80(2):189-193. PubMed ID: 33236165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cutaneous pathology associated with seropositivity for antibodies to SSA (Ro): a clinicopathologic study of 23 adult patients without subacute cutaneous lupus erythematosus.
    Magro CM; Crowson AN
    Am J Dermatopathol; 1999 Apr; 21(2):129-37. PubMed ID: 10218672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subacute cutaneous lupus erythematosus induced by nifedipine.
    Gubinelli E; Cocuroccia B; Girolomoni G
    J Cutan Med Surg; 2003; 7(3):243-6. PubMed ID: 12574905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced lupus erythematosus.
    Marzano AV; Tavecchio S; Menicanti C; Crosti C
    G Ital Dermatol Venereol; 2014 Jun; 149(3):301-9. PubMed ID: 24819757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios.
    Akhtar K; Sravanthi MV; D'Angelo J; Sivapiragasam A
    J Investig Med High Impact Case Rep; 2022; 10():23247096221121408. PubMed ID: 36017984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subacute cutaneous lupus erythematosus induced and exacerbated by proton pump inhibitors.
    Almebayadh M; Regnier-Rosencher E; Carlotti A; Goulvestre C; Le Guern V; Mouthon L; Avril MF; Dupin N
    Dermatology; 2013; 226(2):119-23. PubMed ID: 23548825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taxane associated subacute cutaneous lupus erythematosus.
    Marchetti MA; Noland MM; Dillon PM; Greer KE
    Dermatol Online J; 2013 Aug; 19(8):19259. PubMed ID: 24021438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cemiplimab: A Review in Advanced Cutaneous Squamous Cell Carcinoma.
    Lee A; Duggan S; Deeks ED
    Drugs; 2020 Jun; 80(8):813-819. PubMed ID: 32306208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subacute cutaneous lupus erythematosus presenting in twins.
    Montuno MA; Church AA; Schoch JJ; Andrews ID
    Pediatr Dermatol; 2018 Mar; 35(2):e128-e131. PubMed ID: 29436018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus.
    David-Bajar KM; Bennion SD; DeSpain JD; Golitz LE; Lee LA
    J Invest Dermatol; 1992 Sep; 99(3):251-7. PubMed ID: 1512459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutaneous lupus associated with pembrolizumab therapy for advanced melanoma: a report of three cases.
    Blakeway EA; Elshimy N; Muinonen-Martin A; Marples M; Mathew B; Mitra A
    Melanoma Res; 2019 Jun; 29(3):338-341. PubMed ID: 30762712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subacute cutaneous lupus erythematosus: a paraneoplastic dermatosis?
    Chaudhry SI; Murphy LA; White IR
    Clin Exp Dermatol; 2005 Nov; 30(6):655-8. PubMed ID: 16197381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.